The GTP cyclohydrolase. activity of rat tissues has been studied by means of the measurement of formic acid release and neopterin synthesis from GTP. After gel filtration of a 45%-satd.-(NH4)2SO4 fraction of liver homogenates, three enzyme fractions were separated and named A,, A2 and A3 according to the order of their elution. Fractions Al and A3 displayed an 8-formyl-GTP deformylase activity; no proof of cyclized product has yet been established. This activity was heat-labile and required Mg2+ for maximal activity. Fraction A2 displayed a 'neopterin-synthetase' activity, with dihydroneopterin triphosphate and formic acid formed in stochiometric amounts.
and inhibited by Mg2+. In liver the A2 fraction represented 70-75% of the neopterin synthetase capacity and was inhibited by reduced pterines (sepiapterin, dihydrobiopterin and tetrahydrobiopterin) and to a lesser extent by reduced forms of folic acid.
In kidney and brain, fraction A, and A3 GTP 8-formylhydrolase activities were found in significant amounts, in contrast with the neopterin synthetase activity, which was low and appeared to be confined to the A1* fraction.
BH4 is an essential cofactor for the pterindependent aromatic amino acid hydroxylases (Kaufman, 1964) . BH4 is synthesized from GTP with dihydroneopterin triphosphate as an intermediate. Burg & Brown (1968) described an enzyme, GTP cyclohydrolase I (EC 3.5.4.16) , from Escherichia coli that catalyses the removal of the carbon at ring position 8 of GTP to form formate and dihydroneopterin triphosphate. The occurrence of a GTP cyclohydrolase acting as the first step of pterin synthesis was then demonstrated in a number of bacteria (Cone & Guroff, 1971; Jackson & Shiota, 1971; Yim & Brown, 1976; Iwai et al., 1980) and in higher animals such as Syrian golden hamster (Fukushima et al., 1975a,b) , chicken (Fukushima et al., 1977) , rat (Gal et al., 1978; Lee et al., 1979; Viveros et al., 1981) and human (Blau & Niederwieser, 1983 ). Recent observations designated this enzyme as the rate-limiting step for BH4 synthesis in t To whom reprint requests and correspondence should be sent.
Abbreviations used: BH4, tetrahydrobiopterin [2-amino -6 -(1,2-dihydroxypropyl) - 5,6,7,8-tetrahydropteri- din-4(3H)-onel; h.p.l.c., high-performance liquid chromatography.
Vol. 217 rats (Viveros et al., 1981) and in human (Blau & Niederwieser, 1983) . Niederwieser et al. (1982b) reported the observation of a child with hyperphenylalaninaemia and atypical neurological signs who excreted low amounts of neopterin and biopterin indicating a defect between GTP and dihydroneopterin triphosphate.
The present paper describes properties and distribution of GTP cyclohydrolase activities in rat tissues. Wettswill, Switzerland) , and D-erythro-dihydroneopterin triphosphate was produced by incubation of GTP with partially purified GTP cyclohydrolase I from E. coli (Yim & Brown, 1976 Enzyme assay procedures Enzyme activity was assayed by the fluorescence method described by Fukushima et al. (1977) and by the liberation of radioactive formic acid from [8-14C] GTP by the method of Burg & Brown (1968) . Unless otherwise specified, the standard reaction mixture contained enzyme, 150nmol of GTP, 30Oumol of potassium phosphate buffer, pH 8.0, 6mg of bovine serum albumin and 0.4,umol of EDTA (adjusted to pH 8.0 with KOH) or 30umol of MgCl2, in a total volume of 0.6 ml. Incubation was for 60min at 370C.
Experimental
For the fluorescence method, the incubation was terminated by the addition of ml of 0.1 M-HC1. Oxidation of pterins was performed by addition of 1001u1 of iodine solution (1 g of iodine and 2g of KI in 100ml of water) for 15min. Then 100p1 of 0.1M-ascorbic acid and 0.5ml of 0.4M-Tris base were added. The fluorescence was measured with a Jobin-Yvon JY3 spectrofluorimeter (excitation, 356nm; emission, 454nm) . Standards of neopterin were used for quantification.
For the radioactive method, the incubation was followed by the addition of 1 ml of 1 M-formic acid and 1.5 ml of ethyl acetate. The mixture was shaken and centrifuged, and 0.75 ml of the organic layer was analysed for radioactive formate in an LKB Rackbeta scintillation counter with 5 ml of Biofluor (NEN). Formic acid release was calculated on the basis of a 40% level of extraction of formate by ethyl acetate (39.8 + 0.9% from 10 determinations with H14COOH).
Identification of reaction products
Using similar conditions to those previously described, except the use of 0.05 M-Tris/HCl, pH 8.0, as buffer, a reaction mixture of 1.5 ml-4.5 ml was incubated at 370C for 60min. Then 2ml of 1 M-HCI was added and oxidation was performed by addition of iodine. After addition of ascorbic acid to reduce the excess iodine, the mixture was adjusted to pH 8.0 with 2M-Tris base. Alkaline phosphatase (2mg/ml) was added and the mixture was incubated at 370C for 60min in the dark. Then I ml of 2M-trichloroacetic acid and 501 of 6-methylpteridine (5mg/100ml of 0.1 M-HCI) as internal standard were added. After mixing and centrifugation, pterins in the supernatant were isolated by ion-exchange chromatographies [Dowex 50W (X8, H+ form; 1X2, OH-form)]. The final acid eluate was analysed by an h.p.l.c. procedure as described previously (Dhondt et al., 1981) on Partisil-10 SCX (Whatman).
Gel chromatography ofGTP cyclohydrolases Unless otherwise specified, all operations were carried out at 40C. Rat tissues were homogenized in 4 vol. of 0.05 M-potassium phosphate buffer, pH 8.0, and the homogenate was centrifuged at 12 000g for 10min.
'Heat-treated' homogenates were obtained by heating homogenates in a water bath at 100°C until the temperature reached 600C. Then, homogenates were cooled in an ice bath, centrifuged at 12000g for 10min and subjected to the same procedures described below.
To the supernatant fluids was added a cold saturated solution of (NH4)2SO4 to give a 45%-saturated solution. After the mixture had been stirred for 20min, the resulting precipitate was recovered by centrifugation (20000g for 30min) and suspended in a small volume of 0.05M-potassium phosphate buffer, pH8.0, and then dialysed overnight against the same buffer. The dialysed samples were applied to a Sepharose 6B (Pharmacia) column (1.6cm x 40cm or 2.6cm x 80cm) that had been equilibrated with 0.05M-potassium phosphate buffer, pH8.0. The column was developed in the same buffer at a flow rate of 30ml/h and 2 ml fractions were collected.
Miscellaneous
Dihydrobiopterin affinity chromatography. The coupling of dihydrobiopterin to CH-Sepharose 4B (Pharmacia, Uppsala) was performed by a method derived from that of Cotton (1974) .
Inhibitor studies. When GTP cyclohydrolase activity was assayed in the presence of the tetrahydro-form of pteridines, they were protected from spontaneous oxidation by addition of 4 mM-dithio- A1 was heat-labile and a slight increase (1.4-1.8-fold) in activity occurred when Mg2+ (50mM) was used instead of EDTA.
A2 was strongly inhibited by Mg2+; half-maximal activity was observed at 2.5 mM_Mg2+. Therefore maximal velocity was obtained in the EDTA-containing reaction mixture. This fraction was heatstable; thus, studies of A2 were easily performed on A2 fractions isolated from 'heat-treated' homogenates.
A3 required Mg2+ for maximal activity (EDTA at 0.7 mm completely inhibited the activity) and was heat-labile.
No change in the profile of elution and activities was noted when the homogenization and following steps were performed in the presence of dithiothreitol (5 mM) or KCI (2.5 mM). Dihydroneopterin triphosphate formation. Fluorescent material was produced only by A1 and A2 fractions. The fluorescent material was identified as erythro-dihydroneopterin triphosphate on the basis of a stronger fluorescence after oxidation and the h.p.l.c. separation of oxidized and dephosphorylated products. Standards of D-erythro-neopterin and D-threo-neopterin eluted respectively at 7min and 7.3min and enzymic product co-eluted with the first peak.
Dihydroneopterin triphosphate synthesis was strongly inhibited by Mg2+, whatever the enzyme fraction tested, and the lack of a pterin production was confirmed by h.p.l.c. analysis. The two dihydroneopterin triphosphate synthesis activities were heat-stable. The formation of dihydroneopterin triphosphate and of formic acid from GTP was stochiometric for the A2 fraction (formic acid release/fluorescent product = 1.02 + 0.14; seven experiments), whereas the reaction stochiometry was greater than 1.5 with the A1 fraction separated from 'heat-treated' homogenates (termed A * fraction). Moreover, the formic acid release activity of fraction A1* remained stimulated by Mg2+ (Table 1) . Of the total dihydroneopterin triphosphate synthesis in liver 70-75% was linked to the A2 fraction. Properties ofA2. A large-scale preparation of A2 enzyme has been obtained from 'heat-treated' homogenates (Table 1) . A2 was most active with GTP as substrate. GDP was approximately onesixth as efficient a substrate as GTP. GMP and guanosine did not exert a substrate or an inhibitory effect. The Km for GTP was 47+ 10pM from a double-reciprocal plot (six experiments), whatever the assay method.
The following compounds displayed neither stimulatory nor inhibitory effects: dithiothreitol (5.0mM), f-mercaptoethanol (2.5 mM), p-hydroxymercuribenzoate (2.5 mM), NH4C1 (2.5 mM), KCI (2.5 mM) and phenylalanine (1.2mM). Formate (ammonium or sodium salt) (2.5 mM) and dihydroneopterin triphosphate (0.5 mM), obtained from E. coli, had no effect.
Vol. 217 6-Methyl-and 6,7-dimethyl-tetrahydropteridine were also inhibitory but to a lesser extent. Tetrahydrofolate and dihydrofolate were found to be inhibitors, in contrast with the N5-methyltetrahydrofolate, which had no effect (Fig. 2) .
GTP cyclohydrolase activity in kidney and brain Fig. 3 compares the profiles obtained from 4g tissues samples; activities were measured by the radioactive method.
In kidney and brain the A2 fraction was not identified, whereas A1 and A3 were present. In kidney, the effects of Mg2+ and of heat treatment were similar to those described for liver fractions. In contrast, the brain A1 fraction appeared to be more heat-resistant and more sensitive to Mg2+. In the three tissues, the amount of A3 was in the same range of activity when expressed per g wet wt. of tissue.
Dihydroneopterin triphosphate formation was very low in kidney and in brain, and appeared to be confined to the A1 fraction (data not shown). As in the liver, this synthesis was heat-stable.
Tetrahydrobiopterin, dihydrobiopterin and sepiapterin inhibited [Cl4Gformic acid release (Fig. 2) and neopterin production, whereas totally oxidized biopterin was inefficient. The affinity of dihydrobiopterin for A2 was verified by the capacity of a dihydrobiopterin-Sepharose matrix to retain enzyme activity. A Sepharose 6B A2 fraction (lOml) was applied to an affinity column (1 cm x 1.5 cm) and washed with phosphate buffer. Elution was performed with the same buffer containing 0.2M-NaCl. A blank control was achieved with a CH-Sepharose-4B column (1 cm x 1.5 cm). The enzyme activity appeared only when the salt elution was applied, with a 50% recovery but with only a 2-fold increase of the specific activity.
Discussion
GTP cyclohydrolase activity has been located in many species. However, conflicting results have been obtained in tissues from higher species. A GTP cyclohydrolase that catalyses the synthesis of dihydroneopterin triphosphate from GTP in a onestep reaction was found in chicken liver (Fukushima et al., 1977) , rat adrenal gland (Viveros et al., 1981) and rat and human liver (Blau & Niederwieser, 1983) , whereas Gal et al. (1978) isolated from rat brain three enzymes: two GTP cyclohydrolases ('AI and AII') forming a formamidopyrimidine derivative from GTP and a dihydroneopterin triphosphate synthetase catalysing dihydroneopterin triphosphate synthesis from the formamidopyrimidine ('enzyme B'). (Gal et al., 1978) AI AII The present findings demonstrated the occurrence in liver of three enzyme fractions catalysing the release of formic acid from GTP. A, and A3 rather displayed a 8-formyl-GTP deformylase activity, as no evidence of cyclized product(s) has yet been established, whereas A2 presented a true 'neopterin-synthetase' activity with dihydroneopterin triphosphate and formic acid formed in stochiometric amounts. However, it was also noted that 30% of the neopterin synthetase activity co-eluted with A1. On the basis of the characteristics of this activity (heat-stability and Mg2+ inhibition) it could be speculated that two enzymes are present in the AI fraction.
In kidney and brain fractions A1 and A3 were present, whereas A2 was not identified. In these tissues the 'neopterin-synthetase' activity was linked to the A, heat-resistant fraction (A,*). This finding of efficient 'neopterin-synthetase' activity in liver in contrast with the low activity in other tissues agreed with the data of Fukushima et al. (1975b) in Syrian golden hamster. The present results suggest that the A2 enzyme is specific for the liver.
As a result, our attention was focused on the Vol. 217 (Table 2) . However, in contrast with the results of Fukushima et al. (1977) , the A2 enzyme was found to be strongly inhibited by reduced pteridines and to bind to a dihydrobiopterin-Sepharose matrix. Such behaviour was reported for the GTP cyclohydrolase I from E. coli (Then, 1979) . The end product and intermediates of the biosynthetic pathway of BH4 (Hausermann et al., 1981) are thus potent inhibitors. Consequently a negative-feedback control of the synthesis of BH4 is conceivable. Indirect evidence of such a regulation has been obtained in man from observations of inborn errors of the metabolism of BH4. In the so-called 'dihydrobiopterin-synthetase' deficiency, neopterin accumulates and no, or a reduced amount of, biopterin is synthesized (Niederwieser et al., 1980) . The administration of BH4 or sepiapterin induced a decrease of the excretion of neopterin (Niederwieser et al., 1982a) . In dihydropteridine reductase-deficient patients, who are unable to reduce quinonoid-dihydrobiopterin into BH4, dihydrobiopterin accumulates and the neopterin excretion remained in the normal range (Niederwieser etal., 1980) . The precise mechanism of the inhibition by reduced pteridines is unclear, but evidence has been presented that only hydrogenated forms of pteridines are inhibitory and that 6-and 7-substitutions of the pteridine ring are also of importance.
The intervention of the formamidopyrimidine intermediate (Fig. 4) in the synthesis of dihydroneopterin triphosphate has been extensively discussed but not definitely resolved (Shiota et al., 1967; Yim & Brown, 1976; Gal et al., 1978; Blau & Niederwieser, 1983) . Nevertheless, it is clear that with the present A2 enzyme a direct and stoichiometric production of dihydroneopterin triphosphate was observed.
However, the metabolic role of the A1 and A3 8-formyl-GTP deformylase has not been elucidated and the product(s) of the reaction is not yet known. In micro-organisms, GTP cyclohydrolase is thought to participate in riboflavin synthesis (Foor & Brown, 1975) . More recently, it has been proposed that queuine, a substance found in animal serum and amniotic fluid and a substrate for queuine-guanosine tRNA transglycosidase, is produced from GTP via GTP cyclohydrolase catalysis (Jacobson et al., 1981) . However, the significance of this pathway is not well established and the synthesis of queuine not confirmed in mammals.
